PDF Archive

Easily share your PDF documents with your contacts, on the Web and Social Networks.

Share a file Manage my documents Convert Recover PDF Search Help Contact



COVID 19 Research Remdesivir Intermediates For Research Purpose .pdf


Original filename: COVID-19 Research Remdesivir Intermediates For Research Purpose.pdf
Author: Administrator.AB-202003031417

This PDF 1.7 document has been generated by WPS 文字 / , and has been sent on pdf-archive.com on 26/03/2020 at 08:05, from IP address 103.192.x.x. The current document download page has been viewed 25 times.
File size: 194 KB (3 pages).
Privacy: public file




Download original PDF file









Document preview


Hunan Huateng Pharmaceutical Co. Ltd.

https://en.huatengsci.com

COVID-19 Research : Remdesivir
Intermediates For Research Purpose

COVID-19 Research?
The 2019 novel coronavirus (COVID-19) has spread rapidly since its recent identification in
patients with severe pneumonia in Wuhan, China. The pandemic has spread to over 150
countries and territories. Vaccines and treatment options for COVID-19 are currently being
investigated around the world. There’s some evidence that certain medications may have
the potential to be effective with regard to preventing illness or treating the symptoms of
COVID-19.
In this phase of growing threat, Huateng Pharma plays its parts by providing the
necessary drug intermediates which might be used for the research purpose of coronavirus
treatment. We are able to provide the production of potential COVID-19 drugs
intermediates with capacities varying from gram to kilograms. Learn more>>

Remdesivir Intermediates
Remdesivir, also known as GS-5734, is a novel antiviral drug in the class of nucleotide analogs
developed by Gilead Sciences. In February 2020 Remdesivir was being studied for experimental
treatment of the emergent COVID-19 (novel coronavirus) disease.

Hunan Huateng Pharmaceutical Co. Ltd.

https://en.huatengsci.com

Hunan Huateng Pharmaceutical Co. Ltd.

https://en.huatengsci.com

Baloxavir Marboxil
Intermediates
CAS No. 1985606-14-1
CAS No. 1985607-83-7
CAS No. 2136287-66-4
CAS No. 2136287-68-6


COVID-19 Research  Remdesivir Intermediates For Research Purpose.pdf - page 1/3
COVID-19 Research  Remdesivir Intermediates For Research Purpose.pdf - page 2/3
COVID-19 Research  Remdesivir Intermediates For Research Purpose.pdf - page 3/3

Related documents


what is the difference between api and intermediate
untitled pdf document 1
cdk46 inhibitors for treatment of advanced breast cancer
pharmaceutical intermediates suppliers
indy founded drug firm lands nearly 23m
find pharmaceutical research and development company


Related keywords